Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy.
Publication
, Conference
Scott, SD; Chrischilles, EA; Link, BK; Delgado, DJ; Fridman, M; Lyman, GH
Published in: PHARMACOTHERAPY
2003
Duke Scholars
Published In
PHARMACOTHERAPY
ISSN
0277-0008
Publication Date
2003
Volume
23
Issue
3
Start / End Page
406 / 406
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Scott, S. D., Chrischilles, E. A., Link, B. K., Delgado, D. J., Fridman, M., & Lyman, G. H. (2003). Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy. In PHARMACOTHERAPY (Vol. 23, pp. 406–406).
Scott, S. D., E. A. Chrischilles, B. K. Link, D. J. Delgado, M. Fridman, and G. H. Lyman. “Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy.” In PHARMACOTHERAPY, 23:406–406, 2003.
Scott SD, Chrischilles EA, Link BK, Delgado DJ, Fridman M, Lyman GH. Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy. In: PHARMACOTHERAPY. 2003. p. 406–406.
Scott, S. D., et al. “Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy.” PHARMACOTHERAPY, vol. 23, no. 3, 2003, pp. 406–406.
Scott SD, Chrischilles EA, Link BK, Delgado DJ, Fridman M, Lyman GH. Time to first febrile neutropenia among early stage breast cancer patients receiving adjuvant chemotherapy. PHARMACOTHERAPY. 2003. p. 406–406.
Published In
PHARMACOTHERAPY
ISSN
0277-0008
Publication Date
2003
Volume
23
Issue
3
Start / End Page
406 / 406
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences